Analysts Adjust Price Targets for HCA Healthcare
Multiple financial institutions, including Jefferies, BofA, and KeyBanc, updated their price targets for HCA Healthcare on October 28, 2026.
Stocks · News reference
KeyBanc Maintains Buy Rating and Raises Price Target on HCA Healthcare
KeyBanc analyst Matthew Gillmor has maintained a buy rating on HCA Healthcare while increasing the price target to $490.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Keybanc Maintains Overweight on HCA Healthcare, Raises Price Target to $490
HCA Healthcare Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Results
HCA Healthcare beat Q3 estimates: revenue rose 3.6% to $19.85B, EPS hit $7.22, and FY26 guidance increased; analysts raised price targets.